ConductScience.org, home

Paper39425166

Alternative splicing in ovarian cancer.

Wei L and 6 others. Cell Commun Signal, 2024. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Alternative splicing in ovarian cancer. Papers, record 39425166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39425166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alternative splicing in ovarian cancer.
PubMed
Journal
Cell Commun Signal
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
2.02, provisional
iCite
Revised in PubMed
2026-09-06
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wei LLiwei
2Li YYisheng
3Chen JJiawang
4Wang YYuanmei
5Wu JJianmin
6Yang HHuanming
7Zhang YYi

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ovarian NeoplasmsMajor topic
Alternative SplicingMajor topic
Humans
Female
Animals

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81971064National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References141

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128501461Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer.Exp Cell Res2017https://conductscience.org/library/papers/28501461PubMed
232083075SF3b4: A Versatile Player in Eukaryotic Cells.Front Cell Dev Biol2020https://conductscience.org/library/papers/32083075PubMed
319371633Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.Exp Cell Res2009https://conductscience.org/library/papers/19371633PubMed
429020823Platinum or nonplatinum in recurrent ovarian cancer: that is the question.Future Oncol2017https://conductscience.org/library/papers/29020823PubMed
535210412SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52.Cell Death Dis2022https://conductscience.org/library/papers/35210412PubMed
632332923Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.Oncogene2020https://conductscience.org/library/papers/32332923PubMed
729130517Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.J Cell Biochem2018https://conductscience.org/library/papers/29130517PubMed
812890739Emerging roles of BRCA1 alternative splicing.Mol Pathol2003https://conductscience.org/library/papers/12890739PubMed
927197267The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.Cancer Res2016https://conductscience.org/library/papers/27197267PubMed
1028488700Alternative splicing as a regulator of development and tissue identity.Nat Rev Mol Cell Biol2017https://conductscience.org/library/papers/28488700PubMed
117894493Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.Nat Genet1994https://conductscience.org/library/papers/7894493PubMed
1218245464Multiple alternative splicing markers for ovarian cancer.Cancer Res2008https://conductscience.org/library/papers/18245464PubMed
139010228Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.Oncogene1997https://conductscience.org/library/papers/9010228PubMed
1422471593Architecture of the spliceosome.Biochemistry2012https://conductscience.org/library/papers/22471593PubMed
1535343831Alternative Splicing: A New Therapeutic Target for Ovarian Cancer.Technol Cancer Res Treat2022https://conductscience.org/library/papers/35343831PubMed
1626298390Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.Mol Cancer2015https://conductscience.org/library/papers/26298390PubMed
1733623018Alternative splicing and cancer: a systematic review.Signal Transduct Target Ther2021https://conductscience.org/library/papers/33623018PubMed
1819061484The SR protein family of splicing factors: master regulators of gene expression.Biochem J2009https://conductscience.org/library/papers/19061484PubMed
1916190883PQBP-1 is expressed predominantly in the central nervous system during development.Eur J Neurosci2005https://conductscience.org/library/papers/16190883PubMed
2030863109Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer.Onco Targets Ther2019https://conductscience.org/library/papers/30863109PubMed

See all 141 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42640343Integrated genome-wide high-throughput screening and functional validation identifies Sm proteins as essential splicing regulators for gastric cancer progression.Funct Integr Genomics2026https://conductscience.org/library/papers/42640343PubMed
42633203LncRNA-driven alternative splicing landscapes associate with survival outcomes in ovarian cancer.Noncoding RNA Res2026https://conductscience.org/library/papers/42633203PubMed
42353343Comparative Analysis of Serum and Tissue miRNA Expression Profiles and Regulatory Pathways in Early-Stage Ovarian Cancer Using Public Databases.Int J Mol Sci2026https://conductscience.org/library/papers/42353343PubMed
42211461Integrated RNA-seq and sQTL analysis reveal immune and splicing regulatory features underlying relapse and remission after treatment of Graves' disease.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42211461PubMed
42098443SNRPD2-CPSF7-UBE2K axis drives ovarian cancer progression via alternative splicing-polyadenylation crosstalk.Oncogene2026https://conductscience.org/library/papers/42098443PubMed
42046102Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide.J Transl Med2026https://conductscience.org/library/papers/42046102PubMed
41833929Misregulated alternative splicing in endometriosis: a role for aberrant mRNA variants in endometriotic cell growth.Cell Death Discov2026https://conductscience.org/library/papers/41833929PubMed
41720762SNRPD2-mediated regulation of DDX39B splicing promotes endometrial cancer progression by suppressing the activation of CTSC cryptic exons.Cell Death Dis2026https://conductscience.org/library/papers/41720762PubMed
41452428The protective effect of probiotic therapy on gut microbiota and the activation of ω-oxidation after ovarian cancer surgery.J Cancer Res Clin Oncol2025https://conductscience.org/library/papers/41452428PubMed
41148455LRP11 as a potential predictor of poor prognosis and immune suppression in lung adenocarcinoma.Discov Oncol2025https://conductscience.org/library/papers/41148455PubMed
40996600Extracellular matrix protein 1 in cancer: multifaceted roles in tumor progression, prognosis, and therapeutic targeting.Arch Pharm Res2025https://conductscience.org/library/papers/40996600PubMed
40837768Exploration of the association between SF3B4 and HMGB1 expression and the clinicopathological features and prognosis of gastric cancer.World J Gastrointest Oncol2025https://conductscience.org/library/papers/40837768PubMed
40579921PTBP1 and Cancer: From RNA Regulation to Therapeutic Potential.J Cell Mol Med2025https://conductscience.org/library/papers/40579921PubMed
40555777Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer.Br J Cancer2025https://conductscience.org/library/papers/40555777PubMed
39845971Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy.Front Immunol2024https://conductscience.org/library/papers/39845971PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39425166

GET https://conductscience.org/api/papers/v1/39425166/references?page=2